Clinical trial
Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With…
NCT00219648 · PharmaEngine, Industry · Unknown status
Key facts
| NCT number | NCT00219648 |
|---|---|
| Title | Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
| Official title | A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose- Finding, Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
| Lead sponsor | PharmaEngine, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | PEP03 |
| Start date | Sep 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: